 |
Factor XIII [A2] homodimer, recombinant DNA origin |
|---|---|
| Trade Name | |
| Orphan Indication | Congenital FXIII deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2003-05-21 00:00:00 |
| Sponsor | Novo Nordisk Pharmaceuticals, INc.;100 College Road West;Princeton, New Jersey, 08540 |
